Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials.

被引：0
|
作者：
Menefee, Michael E. [1 ]
Gong, Yutao [1 ]
Mishra-Kalyani, Pallavi Shruti [1 ]
Sridhara, Rajeshwari [1 ]
Kanapuru, Bindu [1 ]
Blumenthal, Gideon Michael [1 ]
Pazdur, Richard [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9105
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC)
    Marmarelis, Melina Elpi
    Grady, Connor B.
    McCoach, Caroline
    Sun, Fangdi
    Liu, Geoffrey
    Patel, Devalben
    Nieva, Jorge J.
    Marrone, Kristen A.
    Velcheti, Vamsidhar
    Liu, Stephen V.
    Patil, Tejas
    Weiss, Jared
    Schwartzman, William
    Villaruz, Liza C.
    Cass, Amanda
    Aisner, Dara L.
    Hwang, Wei-Ting
    Aggarwal, Charu
    Camidge, D. Ross
    Sun, Lova
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update
    Matikas, A.
    Georgoulias, V.
    Kotsakis, A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (11) : 1229 - 1241
  • [43] PHASE II TRIAL OF IMATINIB MESYLATE AND DOCETAXEL IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER
    Papadimitrakopoulou, Vassiliki
    Liu, Suyu
    Fujimoto, Junya
    Wistuba, Ignacio
    Lee, J. J.
    Marom, Edith M.
    Charnsangavej, Chusilp
    Fossella, Frank V.
    Tran, Hai T.
    Blumenschein, George
    Kies, Merrill
    Hong, Waun K.
    Stewart, David J.
    Tsao, Anne
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1235 - S1235
  • [44] Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy
    Dawar, R.
    Gawri, K.
    Rodriguez, E.
    Thammineni, V.
    Saul, E.
    Oliveira Lima Filho, J. O.
    Dempsey, N.
    Khan, K.
    Torres, T.
    Kwon, D.
    Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S239 - S240
  • [45] The role of docetaxel in the multimodal treatment of non-small cell lung cancer
    De Sanctis, Rita
    D'Antoni, Igina
    Del Signore, Ester
    Gori, Bruno
    Longo, Flavia
    CLINICAL MANAGEMENT ISSUES, 2009, 3 (02) : 63 - 69
  • [46] Docetaxel: Meeting the challenge of non-small cell lung cancer management
    LeChevalier, T
    ANTI-CANCER DRUGS, 1995, 6 : 13 - 17
  • [47] Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer
    Georgoulias, V
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Papadakis, E
    Bouros, D
    Apostolopoulou, F
    Georgopoulou, T
    Agelidou, M
    Souglakos, J
    Halkiadakis, G
    Hatzidaki, D
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : S9 - S14
  • [48] Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer
    Miller, V
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 12 - 14
  • [49] The current status of docetaxel for advanced non-small cell lung cancer
    Green, MR
    ANTI-CANCER DRUGS, 2001, 12 : S11 - S16
  • [50] Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 4 - 8
12345